Clinical Implications of Drug-Resistant Streptococcus pneumoniae as a Cause of Community Acquired Pneumonia.
10.12701/yujm.2011.28.1.13
- Author:
Kyeong Cheol SHIN
1
Author Information
1. Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea. shin1014@ynu.ac.kr
- Publication Type:Review
- Keywords:
Streptococcus pneumonia;
Drug-resistant;
Pneumonia
- MeSH:
Anti-Bacterial Agents;
Communicable Diseases;
Delivery of Health Care;
Drug Resistance, Microbial;
Hospitalization;
Infection Control;
Korea;
Meningitis;
Otitis Media;
Penicillin Resistance;
Pneumonia;
Sinusitis;
Streptococcus;
Streptococcus pneumoniae;
Vaccination
- From:Yeungnam University Journal of Medicine
2011;28(1):13-19
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The emergence of antibiotic-resistant pathogens is a serious clinical problem in the treatment of infectious diseases that increase mortality, morbidity, hospitalization length, and the cost of healthcare. In particular, Streptococcus pneumoniae is a major etiologic pathogen of pneumonia, sinusitis, otitis media, and meningitis. As the definition of penicillin resistance to S. pneumoniae was recently changed, macrolide-resistant S. pneumoniae is a major resistant pathogen in the community. Infections caused by antibiotic-resistant strains are associated with incorrect use of antibiotics and critical clinical outcomes. For the appropriate use of antibiotics to treat infections, physicians always should have up-to-date information on the current epidemiologic status of antibiotic resistance for common pathogens and their susceptibility to antimicrobials. Appropriate selection of antimicrobials, strict control of infection, vaccination, and development of a feasible national policy of infection control are important strategies for the control of antimicrobial resistance. This review article focuses on the current status of antibiotic-resistant S. pneumoniae in community-acquired pneumonia in Korea.
